期刊文献+

PPARγ2内源性配体对成骨细胞骨代谢相关基因表达的影响 被引量:3

Influence of peroxisome proliferator activated receptor γ2 endogenous ligands on mRNA expression of bone metabolism related genes in osteoblastic cells
原文传递
导出
摘要 目的探讨PPAR72内源性配体氧化低密度脂蛋白(Ox-LDL)、15脱氧一前列腺素J2(15d—PGJ2)、白三烯B4(LTB4)在骨代谢中的作用。方法体外培养大鼠成骨细胞,分别加入不同浓度Ox—LDL、15d.PGJ2、LTB4干预24h,RT-PCR检测成骨细胞PPARγ2、NF-kB活化受体配体(RANKL)、碱性磷酸酶(ALP)、护骨素mRNA表达水平,分别比较上述3种PPARγ2内源性配体对骨代谢相关基因表达的影响。结果不同浓度Ox-LDL、15d-PGJ2、LTB4均呈剂量依赖性下调成骨细胞RANKL、ALP、护骨素mRNA的表达水平,同时呈剂量依赖性上调PPARγ2 mRNA的表达水平,组间比较差异有统计学意义(P〈0.05或P〈0.01)。结论PPARγ2内源性活化配体Ox-LDL、15d-PGJ2、LTB4可能通过激活PPARγ2转录活性抑制成骨细胞成骨标记物基因的表达,从而参与增龄相关的骨质疏松的发病过程。 Objective To observe the effect of oxidized low-density lipoproteins (Ox-LDL), 15-Deoxy- △ 12,14.prostaglandin J2 ( 15d-PGJ2 ) , leukotrienes 114 ( LTB4 ) on mRNA expressions of peroxisome proliferator activated receptor γ2 ( PPART2 ), receptor activator of NF-KB ligand ( RANKL), alkaline phosphatase ( ALP), and osteoprotegerin(OPG) in osteoblastic cells of rats; and to investigate the influence of these PPARγ2 endogenous ligands on bone metabolism. Methods Rat osteoblastic cells were cultured in vitro for 24 h in medium with different PPARγ2 endogenous ligands at various concentrations ( the final concentrations of Ox-LDL were 0, 12. 5, 25, 50 μg/ml; the final concentrations of 15d-PGJ2 were 0, 10, 20, 30 μmol/L; the final concentrations of LTB4 were 0, O. 1, 1.0, 10 μmol/L). RT-PCR was performed to determine the mRNA expressions of PPARγ2, RANKL, ALP, and OPG in osteoblastic cells. Results RT-PCR analysis showed that Ox-LDL, 15d-PGJ2 , and LTB4 all down-regulated the mRNA expressions of RANKL, ALP, and OPG, while up-regulated the mRNA expressions of PPARγ2 in osteoblastic ceils in a dose-dependent manner. Significant differences were found in interclass comparisons( P〈0. 05 or P〈 0.01 ). Conclusions These findings suggest that Ox-LDL, 15d-PGJ2, and LTB4 suppress the expressions of osteogenic genes through activating the transcription activity of PPARγ2, and this may be a plausible mechanism of senile osteoporosis.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2012年第3期221-225,共5页 Chinese Journal of Endocrinology and Metabolism
基金 山西省卫生厅科技攻关计划项目(200911)
关键词 过氧化物酶体增殖物激活受体γ2 成骨细胞 骨代谢 骨质疏松 Peroxisome proliferator activated receptor γ2 Osteoblastic cells Bone metabolism Osteoporosis
  • 相关文献

参考文献16

  • 1Jackson SM, Demer LL. Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts. FEBS Lett, 2000,471 : 119-124.
  • 2Ali AA, Weinstein RS, Stewart SA, et al. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology, 2005,146 : 1226-1235.
  • 3Maurin AC, Chavassieux PM, Meunier PJ. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids. Calcif Tissue Int, 2005,76:385-392.
  • 4Lecka-Czernik B, Gubrij I, Moerman E, et al. Inhibition of Osf2/ Cbfal expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem, 1999,74 : 356-371.
  • 5Akune T, Ohba S, Kamekura S, et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest, 2004,113:846-855.
  • 6Soroceanu MA, Miao D, Bai XY, et al. Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis. J Endocrinol, 2004,183:203-216.
  • 7Hamel P, Abed E, Brissette L, et al. Characterization of oxidized low- density lipoprotein-induced hormesis-like effects in osteoblastic cells. Am J Physiol Cell Physiol, 2008,294 : C1021 -C1033.
  • 8Brodeur MR, Brissette L, Falstrauh L, et al. Influence of oxidized low- density lipoproteins (LDL) on the viability of osteoblastic ceils. Free Radic Biol Med, 2008,44:506-517.
  • 9Brodeur MR, Brissette L, Falstrauh L, et al. HDL reduces the association and modulates the metabolism of oxidized LDL by osteoblastic ceils: a protection against cell death. J Cell Biochem, 2008,105 : 1374-1385.
  • 10Khan E, Abu-Amer Y. Activation of peroxisome proliferator-activated receptor-γ inhibits differentiation of preosteoblasts. J Lab Clin Med, 2003,142:29-34.

同被引文献50

  • 1张云林,蒋岳霞,唐四元.绝经后女性血清网膜素-1与骨密度的关系[J].中南大学学报(医学版),2014,39(4):389-394. 被引量:1
  • 2Wahli W, Michalik L. PPARs at the crossroads of lipid signalingand inflammation [ J ]. Trends Endocrinol Metab, 2012,23 ( 7 ) : 351-363.
  • 3de Lange P, Lombardi A, Silvestri E, et al. Peroxisome prolifera- tor-activated receptor delta: a conserved director of lipid homeosta- sis through regulation of the oxidative capacity of muscle [ J ]. PPAR Res, 2008,2008 : 172676.
  • 4Szanto A, Nagy L. The many faces of PPARgamma: anti-inflamma- tory by any means? [ J]. Immunobiology, 2008,213 (9-10) :789- 803.
  • 5Aekert-Bieknell C, Rosen C. The Genetics of PPARG and the Skeleton[ J]. PPAR Res, 2006,2006:93258.
  • 6Lin TH, Tang CH, Wu K, et al. 15-deoxy-A(12,14) -prostaglan- din-J2 and ciglitazone inhibit TNF-c~-induced matrix metalloprotei- nase 13 production via the antagonism of NF-KI3 activation in hu- man synovial fibroblasts [ J]. J Cell Physiol, 2011,226 ( 12 ) : 3242-3250.
  • 7Strans DS, Pascual G, Li M, et al. 15-deoxy-deha 12,14-prosta- glandin J'2 inhibits multiple steps in the NF-kappa B signaling pathway[J]. Proc Natl Acad Sci U S A, 2000, 97 (9): 4844-4849.
  • 8Li M, Pascual G, Glass CK. Peroxisome proliferator-activated re- ceptor gamma-dependent repression of the inducible nitric oxide synthasegene[ J]. Mol Cell Biol, 2000,20( 13 ) :4699-4707.
  • 9Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human hom- ologue of the Drosophila Toll protein signals activation of adaptive immunity[ J]. Nature, 1997,388(6640) :394-397.
  • 10Darnay BG, Besse A, Poblenz AT, et al. TRAFs in RANK signa- ling[ J~. Adv Exp Med Biol, 2007,597 : 152-159.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部